Guard Medical Inc. - Company Research Report

Company Overview

• Name: Guard Medical Inc.

• Mission of the Company: Guard Medical is committed to improving the lives of surgical patients through innovative, cost-effective, and easy-to-use wound healing technologies.

• Founded By: No information is available

• Headquarters: 1221 Brickell Avenue, Suite 900, Miami, FL 33131

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Guard Medical is known for its novel NPseal dressing, a product that delivers Negative Pressure Wound Therapy (NPWT) to promote wound healing and reduce the risk of surgical site complications.

Key People

• Machiel Van Der Leest: President & Founder. He is a seasoned medical device professional with executive experience and numerous patents.

• Dr. Frederick Cornhill: CSO & Founder. An expert in MedTech startups with over 40 patents and substantial academic and commercial experience.

• Laurence Lefebvre: COO & Founder. Experienced in medical technology development and holds an MBA from Harvard Business School.

• Gene Paik: Vice President of Sales & Marketing. Over 20 years of strategic leadership experience primarily in healthcare.

• Sang Lee, MD: Founder. A leading expert in laparoscopic colorectal and endoluminal surgeries with numerous peer-reviewed publications.

Board of Directors

• Philippe Boucheron: Deputy Chief of Life Sciences Investment at Bpifrance.

• Philippe Dhamelincourt: Co-founder and Chairman of Matignon Investissement & Gestion.

• Phil Cooper: Experienced in the medical device industry.

• Thierry Sarda: Healthcare sector transformation leader.

Products

NPseal

• Description: NPseal is a revolutionary dressing designed for negative pressure wound therapy that is easy to use and cost-effective.

• Key Features:

• Ultraportable: Allows patients to return to normal activities.

• No Vibration: Ensures patient comfort.

• No Straps or Tubes: Simplifies the healing process.

• No Batteries: Further reduces complexity and cost.

• Increased Wear Time: Cleared for up to 6 days of wear.

• Multiple Sizes: Available for wounds up to 25cm, accommodating various surgical needs.

Recent Developments

• FDA 510(k) Clearance: Achieved clearance for increased wear time and additional large sizes of NPseal, opening opportunities in the orthopedic market (August 19, 2024).

• Series B Investment: Secured an $11 million investment to support commercialization efforts (April 6, 2022).

• Product Studies and Development:

• Successful completion of the first post-market study (February 8, 2022).

• Continued expansion with FDA clearances for new product sizes (February 15, 2022).

• Financial Developments:

• Follow-on $5 million cash infusion supporting product advancement (June 29, 2020).

Contact Information

• Email: info@guard-medical.com

• Address: Guard Medical Inc., 1221 Brickell Avenue, Suite 900, Miami, FL 33131